Medical Journals provide a platform for outstanding research around the globe in the field of medicine. These scholarly journals aim to contribute to the progress and application of scientific discoveries, by providing free access to the research information. The published work reaches the general public and the scientific community immediately after publication, thus providing higher citation rates for the author. Medical Journals are supported by 5000 internationally renowned editorial board members and a high quality review board. Medical Journals use online Editorial Manager System for quick and high quality review process. Articles of Medical journals are subjected to peer reviewing and these are included in the standard indexing databases like ISI, Scopus, EBSCO, CAS, HINARI etc. All the articles published in Medical journals are permanently archived in respective peer reviewed journals thus providing unrestricted utilization and requisition of the scientific information.
Dysregulated expression of microRNAs (miRNAs) has been observed in many tumors including bladder cancer, revealing that these molecules may be potential diagnostic/prognostic tools. Interestingly, miRNAs have been isolated from different biological specimens, showing that their altered expression may be detected in surrogate tissues, including plasma.The rapid development of next generation sequencing (NGS) technology has provided novel information about miRNA expression in BC and seems to be superior to array-/PCR-based methods that can investigate a limited number of known miRNAs. So far only few studies investigated miRNA signatures in BC by NGS and exclusively on BC tissues. To investigate an expression signature in surrogate tissues such as plasma, would be a useful alternative to reduce invasiveness of biopsies, allowing repetitive samplings during follow-up and reducing health care costs for both screening strategy and therapies/monitoring.In this project, miRNA expression profiles will be characterized in 48 plasma samples from BC patients and 48 healthy controls using NGS and systems biology approach with the aim to identify miRNA signatures able to better estimate individual BC risk or that may help as predictive and prognostic markers. (Barbara Pardini, Francesca Cordero, Alessandra Allione, SimonettaGuarrera, Giovanni Fiorito, Fabio Rosa, Alessia Russo, Cornelia Di Gaetano, Federica Modica, Paolo Vineis, Carlotta Sacerdote and Giuseppe Matullo, A next generation sequencing approach for plasma microRNA profiling in bladder cancer)
Last date updated on September, 2024
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi